Biddick Allison A, Bacek Lenore M, Taylor Amanda R
Auburn University College of Veterinary Medicine, Auburn, AL, 36849.
J Vet Emerg Crit Care (San Antonio). 2018 Mar;28(2):157-162. doi: 10.1111/vec.12693. Epub 2018 Feb 8.
To describe a serious adverse event as a result of rapid intravenous injection of undiluted levetiracetam in a dog.
An 8-year-old female spayed Chihuahua was evaluated for cluster seizures and tachypnea. The patient was administered an intravenous dose of undiluted levetiracetam (60 mg/kg) and immediately developed tachycardia, hyperglycemia, hypotension, and a dull mentation. The patient's blood pressure and mentation did not respond to intravenous fluid boluses but improved immediately after administration of epinephrine intravenously. The patient subsequently developed respiratory failure necessitating mechanical ventilation, prior to cardiac arrest. Necropsy examination noted a pulmonary inflammatory cell infiltrate, pulmonary edema, and interstitial pneumonia.
This report documents a serious adverse event associated with intravenous levetiracetam administration to a dog.
描述一只犬快速静脉注射未稀释的左乙拉西坦后出现的严重不良事件。
一只8岁已绝育的雌性吉娃娃犬因簇状癫痫发作和气促接受评估。给该患者静脉注射一剂未稀释的左乙拉西坦(60mg/kg)后,立即出现心动过速、高血糖、低血压和精神沉郁。患者的血压和精神状态对静脉推注液体无反应,但静脉注射肾上腺素后立即改善。患者随后出现呼吸衰竭,在心脏骤停前需要机械通气。尸检发现肺部有炎性细胞浸润、肺水肿和间质性肺炎。
本报告记录了犬静脉注射左乙拉西坦相关的严重不良事件。